Richard Montes

Critic
DISC Type : C

Sr Director, CMC Statistics at Alnylam Pharmaceuticals

Cambridge, Massachusetts, United States

Overview

Richard Montes is the Senior Director of CMC Statistics at Alnylam Pharmaceuticals, bringing over 25 years of experience in pharmaceutical drug development. A PhD graduate from Georgia Institute of Technology, his expertise spans RNAi, biosimilars, and biologics, with a focus on statistical strategies for process optimization and regulatory approval.

He played a key role in influencing the FDAs regulatory framework for demonstrating analytical similarity in biosimilars during his time at Hospira/Pfizer.

Personality Overview

Critic

Negotiator

ROI Driven

They don’t appreciate bells and whistles unless backed by data.  They are quite likely to negotiate on pricing or other key terms. They choose to analyze logically and value facts to emotions.

Topics They Care About

CMC Statistics
His core expertise for over 25 years, focusing on product life cycle, stability trending, and control strategies. He serves on conference committees related to this topic.
Drug Process Optimization
He has published case studies on using Design of Experiments (DOE) and Optimal Design to improve the efficiency and robustness of chemical processes in drug manufacturing.
Biosimilar Regulation
He has direct experience engaging with the FDA to influence the regulatory framework for the statistical demonstration of analytical similarity for biosimilar drugs.

Media Appearances

Richard has no verified media appearances

Work History

3-2025
Sr Director, CMC Statistics at Alnylam Pharmaceuticals
5-2019 - 2-2025
Director, Statistics - CMC, TOQ at Alnylam Pharmaceuticals
5-2014 - 5-2019
Associate Director, Statistics - Biosimilars Pharmaceutical Sciences at Hospira, a Pfizer company
2-2012 - 4-2014
Manager Quality Statistics at Bristol-Myers Squibb
8-2007 - 2-2012
Sr. Research Statistician (CMC, Non-clinical) at Merck

Education

PhD from Georgia Institute of Technology
Applied Statistics from Pennsylvania State University (online)

More Information

Social Presence :

Prographics :

Exp : 21 Location : Cambridge, Massachusetts, United States Job Level : Senior Designation : Sr Director, CMC Statistics at Alnylam Pharmaceuticals
URL has been copied!

Insights For Selling To Richard

During A Call Or A Meeting

DO's

  • If you can, show them industry reports or analyst comments instead of sharing anecdotal stories
  • Keep some extra margin while sharing pricing, they are likely to negotiate later
  • Leverage facts and figures wherever possible; use percentages, numbers etc.

DONT's

  • Don’t try too hard to build a relationship with them
  • Make extra effort to not seem pushy or confrontational
  • Do not use very emotional or colorful language

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Richard is

  • Proven ROI, pricing and objective proof points are the factors that sway their decision.
  • Will you ever get a clear answer from Richard

  • They are comfortable saying no if they are convinced that it is the correct decision.

Insights For Deal Planning

    How fast (or slow) will Richard move?

  • They are neither the fastest nor the slowest decision makers, they are somewhere in the middle.
  • Can Richard take some risk or not?

  • They can bear some risk if their analysis backs the decision.

You And Richard

Personality Compatibility


Other Alnylam Pharmaceuticals Employees

Explore more public profiles from related professionals at the same organization.

More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.